Phase 2 Treatability Sample Descriptions Sample Clauses

Phase 2 Treatability Sample Descriptions. Sample Source Date Initial Toxicitya (%) Number of Analyses Standard Deviationb Coefficient of Variationb (%) Automobile Service Area Samples B 7/10/90 78 28 7.6 9.8 C 7/21/90 34 42 2.9 8.5 E 8/19/90 43 74 1.3 3.0 H 10/17/90 50 88 1.5 3.0 Industrial Lo D ading & Parking 8/2/90 Area Samples 67 74 2.1 3.1 F 9/12/90 31 88 1.5 4.9 G 10/3/90 53 88 3.0 5.7 I 10/24/90 55 89 1.9 3.4 J 11/5/90 49 89 1.1 2.3 K 11/9/90 28 89 2.2 8.1 Automobile Salvage Yard Samples L 11/28/90 26 89 1.4 5.5 M 12/3/90 54 89 1.8 3.4 a Toxicity measured as percent light reduction after 35 minute exposure. b Applies to replicate samples only.
AutoNDA by SimpleDocs

Related to Phase 2 Treatability Sample Descriptions

  • Product Description The lead products covered by this Settlement Agreement is limited to following Amazon Identification Number (ASIN) B0BBMRLNV9, with the description, "Lesnow 63-37 Tin Lead Rosin Core Solder Wire for Electrical Soldering 0.8mm Soldering Wire Electronics Solder Content Solder Flux 1.8% (0.8mm, 50g)," which was offered for sale by the Settling Entity on xxxxxx.xxx, hereinafter the “Product” or “Products.”

  • Project Description In two or three brief sentences, provide a concise description of your exhibition. Include the subject matter, type of objects to be included (paintings, sculpture, manuscripts, etc.), those responsible for organizing the exhibition, and catalogue author(s).

  • System Description The DLCS is a network consisting of devices which are remotely controlled over RF transmission equipment by the PowerCAMPTM Software or equivalent. CL&P shall have access to the PowerCAMP™ LMS (as defined below) via the web interface. The PowerCAMPTM LMS shall include the software and hardware necessary to manage the Control Devices installed at the End-use Equipment at Participating Facilities. The PowerCAMPTM LMS includes AER’s PowerCAMPTM Server and PowerCAMPTM Suite, networking equipment, and third party software. PowerCAMPTM LMS Hardware

  • Technical Standards Applicable to a Wind Generating Plant i. Low Voltage Ride-Through (LVRT) Capability A wind generating plant shall be able to remain online during voltage disturbances up to the time periods and associated voltage levels set forth in the standard below. The LVRT standard provides for a transition period standard and a post-transition period standard.

  • Contract Description The Description and Location of the Contract and related project(s) are as follows.

  • General specifications 6.1.1. A vehicle and its electrical/electronic system(s) or ESA(s) shall be so designed, constructed and fitted as to enable the vehicle, in normal conditions of use, to comply with the requirements of this Regulation.

  • Technical Specifications The Technical Specifications furnished on the CD are intended to establish the standards for quality, performance and technical requirements for all labor, workmanship, material, methods and equipment necessary to complete the Work. When specifications and drawings are provided or referenced by the County, these are to be considered part of the Scope of Work, and to be specifically documented in the Detailed Scope of Work. For convenience, the County supplied specifications, if any, and the Technical Specifications furnished on the CD.

  • Prescription Drug Quantity Limits We limit the quantity of certain prescription drugs that you can get at one time for safety, cost-effectiveness and medical appropriateness reasons. Our clinical criteria for quantity limits are subject to our periodic review and modification. Quantity limits may restrict: • the amount of pills dispensed per thirty (30) day period; • the number of prescriptions ordered in a specified time period; or • the number of prescriptions ordered by a provider, or multiple providers. Our formulary indicates which prescription drugs have a quantity limit. Types of Pharmacies Prescription drugs and diabetic equipment or supplies can be bought from the following types of pharmacies: • Retail pharmacies. These dispense prescription drugs and diabetic equipment or supplies. • Mail order pharmacies. These dispense maintenance and non-maintenance prescription drugs and diabetic equipment or supplies. • Specialty pharmacies. These dispense specialty prescription drugs, defined as such on our formulary. For information about our network retail, mail order, and specialty pharmacies, visit our website or call our Customer Service Department.

  • Registry Performance Specifications Registry Performance Specifications for operation of the TLD will be as set forth in Specification 10 attached hereto (“Specification 10”). Registry Operator shall comply with such Performance Specifications and, for a period of at least one (1) year, shall keep technical and operational records sufficient to evidence compliance with such specifications for each calendar year during the Term.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!